(Q61892603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

6 December 2019

main subject

1 reference

inferred from title

author

Ioannis E. Koutroubakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

E Petinaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

E Anagnostopoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

H Kritikos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

I A Mouzas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

E A Kouroumalis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

O N Manousos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

2507-2512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9824143%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1026602803622

6 December 2019

exact match

0 references

cites work

Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases

1 reference

12 December 2020

[Prevalence and role of anticardiolipin antibodies in Crohn disease]

1 reference

12 December 2020

Inherited disorders of coagulation appear to protect against inflammatory bowel disease

1 reference

12 December 2020

Hemostatic alterations in inflammatory bowel disease: response to therapy

1 reference

12 December 2020

Paradoxical response to heparin in 10 patients with ulcerative colitis

1 reference

12 December 2020

Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.

1 reference

12 December 2020

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

1 reference

12 December 2020

Vascular complications of inflammatory bowel disease

1 reference

12 December 2020

Classification of inflammatory bowel disease

1 reference

12 December 2020

Circulating von Willebrand factor in inflammatory bowel disease

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies

1 reference

12 December 2020

Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules

1 reference

12 December 2020

Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis

1 reference

12 December 2020

Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management

1 reference

12 December 2020

Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis

1 reference

12 December 2020

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies in inflammatory bowel disease

1 reference

12 December 2020

Free protein S deficiency in patients with chronic inflammatory bowel disease

1 reference

12 December 2020

Prevalence and significance of anticardiolipin antibodies in Crohn's disease

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

12 December 2020

Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden

1 reference

12 December 2020

beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway

1 reference

12 December 2020

Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay

1 reference

12 December 2020

Binding of beta 2 glycoprotein I to activated polystyrene and its recognition by human IgG autoantibodies

1 reference

12 December 2020

Requirement of beta 2 glycoprotein I as cofactor in the binding for IgM and IgA anticardiolipin antibodies

1 reference

12 December 2020

Thrombotic vascular risk factors in inflammatory bowel disease

1 reference

12 December 2020

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

1 reference

12 December 2020

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

1 reference

12 December 2020

Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis

1 reference

12 December 2020

Thromboembolism in inflammatory bowel disease: role of platelets

1 reference

12 December 2020

Coagulation studies in ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies

1 reference

12 December 2020

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

12 December 2020

Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome

1 reference

12 December 2020

Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications

1 reference

12 December 2020

Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant

1 reference

12 December 2020

Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements

1 reference

12 December 2020

Hemostatic abnormalities in inflammatory bowel disease

1 reference

12 December 2020

Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies.

1 reference

12 December 2020

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

1 reference

12 December 2020